Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection.


Journal

Drug and alcohol dependence reports
ISSN: 2772-7246
Titre abrégé: Drug Alcohol Depend Rep
Pays: Netherlands
ID NLM: 9918350383506676

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 13 10 2021
revised: 04 02 2022
accepted: 07 03 2022
entrez: 27 2 2023
pubmed: 28 2 2023
medline: 28 2 2023
Statut: epublish

Résumé

•We developed a two-session behavioral intervention to prevent HCV reinfection.•The intervention was piloted at an OTP and integrated into HCV treatment.•Baseline data showed limited knowledge & application of safer injection practices.•Implementation barriers included logistics and the lack of financial incentive.•Adaptations addressed barriers, yielding a more feasible and acceptable intervention.

Identifiants

pubmed: 36845980
doi: 10.1016/j.dadr.2022.100038
pii: S2772-7246(22)00016-6
pmc: PMC9948939
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100038

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© 2022 The Authors. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

No conflict declared

Références

Int J Drug Policy. 2019 Oct;72:1-10
pubmed: 31345644
Curr HIV/AIDS Rep. 2008 Nov;5(4):193-203
pubmed: 18838059
Harm Reduct J. 2009 Dec 15;6:36
pubmed: 20003518
Ann Intern Med. 2017 May 02;166(9):637-648
pubmed: 28319996
J Hepatol. 2017 Feb;66(2):267-269
pubmed: 27816493
AIDS Behav. 2005 Dec;9(4):495-504
pubmed: 16237501
Am J Epidemiol. 2003 Feb 15;157(4):376; author reply 376-8
pubmed: 12578809
J Hepatol. 2016 Oct;65(1 Suppl):S33-S45
pubmed: 27641987
J Subst Abuse Treat. 2017 Apr;75:49-53
pubmed: 28237054
Int J Drug Policy. 2015 Oct;26(10):958-62
pubmed: 26072105
Infect Dis Clin North Am. 2018 Jun;32(2):371-393
pubmed: 29778261
Clin Infect Dis. 2020 Jun 10;70(12):2703-2705
pubmed: 31346595
Addiction. 2002 Oct;97(10):1277-87
pubmed: 12359032
Clin Infect Dis. 2020 May 23;70(11):2355-2365
pubmed: 31513710
Psychol Bull. 1992 May;111(3):455-74
pubmed: 1594721
J Hepatol. 2020 Apr;72(4):643-657
pubmed: 31785345
J Viral Hepat. 2018 Mar;25(3):220-227
pubmed: 29316030
AIDS Behav. 2014 Mar;18(3):452-63
pubmed: 23921583

Auteurs

Adam Viera (A)

Department of Social and Behavioral Sciences, Yale University School of Public Health, New Haven, CT, USA.
Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA.

Lauretta E Grau (LE)

Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA.

Jeffrey D Fisher (JD)

Department of Psychological Sciences and the Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut, Storrs, CT USA.

Scott O Farnum (SO)

APT Foundation, Inc, New Haven, CT USA.

Jeanette M Tetrault (JM)

Department of Internal Medicine and the Yale Addiction Medicine Program, Yale University School of Public Health, New Haven, CT, USA.

Greg Scott (G)

Department of Sociology, DePaul University, Chicago, IL USA.

Robert Heimer (R)

Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA.

Classifications MeSH